| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 19:01:23 UTC |
|---|
| Updated at | 2024-09-10 19:01:24 UTC |
|---|
| NP-MRD ID | NP0334585 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Sertraline |
|---|
| Description | Sertraline, also known as CP 51974 or zoloft, belongs to the class of organic compounds known as tametralines. Tametralines are compounds containing a tametraline moiety, which consists of a tetrahydronaphthalene linked to a phenyl group to form N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine skeleton. Sertraline is a very strong basic compound (based on its pKa). Sertraline was first documented in 1996 (PMID: 8645336). Sertraline is a potentially toxic compound (PMID: 15932816) (PMID: 16213473) (PMID: 10831484) (PMID: 15547048). |
|---|
| Structure | CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12 InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (+)-Sertraline | ChEBI | | (1S,4S)-Sertraline | ChEBI | | (1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine | ChEBI | | cis-(+)-Sertraline | ChEBI | | CP 51974 | ChEBI | | Sertralina | ChEBI | | Sertralinum | ChEBI | | Sertraline hydrochloride | HMDB | | Zoloft | HMDB | | Besitran | HMDB | | Gen sertraline | HMDB | | Novo sertraline | HMDB | | Parke davis brand OF sertraline hydrochloride | HMDB | | Ratiopharm brand OF sertraline hydrochloride | HMDB | | Rhoxal sertraline | HMDB | | Sertraline hydrochloride (1S-cis)-isomer | HMDB | | Altruline | HMDB | | Lustral | HMDB | | Novo-sertraline | HMDB | | Rhoxalpharma brand OF sertraline hydrochloride | HMDB | | Roerig brand OF sertraline hydrochloride | HMDB | | Sealdin | HMDB | | Ratio sertraline | HMDB | | Ratio-sertraline | HMDB | | Apo sertraline | HMDB | | Apo-sertraline | HMDB | | Aremis | HMDB | | Boehringer ingelheim brand OF sertraline hydrochloride | HMDB | | Gladem | HMDB | | Pfizer brand OF sertraline hydrochloride | HMDB | | Apotex brand OF sertraline hydrochloride | HMDB | | Esteve brand OF sertraline hydrochloride | HMDB | | Gen-sertraline | HMDB | | Genpharm brand OF sertraline hydrochloride | HMDB | | Hydrochloride, sertraline | HMDB | | Lacer brand OF sertraline hydrochloride | HMDB | | Novopharm brand OF sertraline hydrochloride | HMDB | | Rhoxal-sertraline | HMDB |
|
|---|
| Chemical Formula | C17H17Cl2N |
|---|
| Average Mass | 306.2300 Da |
|---|
| Monoisotopic Mass | 305.07380 Da |
|---|
| IUPAC Name | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine |
|---|
| Traditional Name | sertraline |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12 |
|---|
| InChI Identifier | InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1 |
|---|
| InChI Key | VGKDLMBJGBXTGI-SJCJKPOMSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as tametralines. Tametralines are compounds containing a tametraline moiety, which consists of a tetrahydronaphthalene linked to a phenyl group to form N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine skeleton. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Tetralins |
|---|
| Sub Class | Tametralines |
|---|
| Direct Parent | Tametralines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Tametraline
- 1,2-dichlorobenzene
- Chlorobenzene
- Halobenzene
- Aralkylamine
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Secondary aliphatic amine
- Secondary amine
- Organohalogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Organochloride
- Organonitrogen compound
- Aromatic homopolycyclic compound
|
|---|
| Molecular Framework | Aromatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Agnel M, Esnaud H, Langer SZ, Graham D: Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter. Biochem Pharmacol. 1996 May 3;51(9):1145-51. doi: 10.1016/0006-2952(96)00028-7. [PubMed:8645336 ]
- Serebruany VL, Suckow RF, Cooper TB, O'Connor CM, Malinin AI, Krishnan KR, van Zyl LT, Lekht V, Glassman AH: Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. Am J Psychiatry. 2005 Jun;162(6):1165-70. doi: 10.1176/appi.ajp.162.6.1165. [PubMed:15932816 ]
- Parsey RV, Kent JM, Oquendo MA, Richards MC, Pratap M, Cooper TB, Arango V, Mann JJ: Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography. Biol Psychiatry. 2006 May 1;59(9):821-8. doi: 10.1016/j.biopsych.2005.08.010. Epub 2005 Oct 6. [PubMed:16213473 ]
- Markovitz JH, Shuster JL, Chitwood WS, May RS, Tolbert LC: Platelet activation in depression and effects of sertraline treatment: An open-label study. Am J Psychiatry. 2000 Jun;157(6):1006-8. doi: 10.1176/appi.ajp.157.6.1006. [PubMed:10831484 ]
- Obach RS, Cox LM, Tremaine LM: Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study. Drug Metab Dispos. 2005 Feb;33(2):262-70. doi: 10.1124/dmd.104.002428. Epub 2004 Nov 16. [PubMed:15547048 ]
|
|---|